Will identifying or targeting altered marker expression in response to cytotoxic therapy be of prognostic or therapeutic value?

Christopher H. Crane; Howard D. Thames; Stanley R. Hamilton

doi:10.1200/JCO.2003.04.156

Will identifying or targeting altered marker expression in response to cytotoxic therapy be of prognostic or therapeutic value?

Christopher H. Crane, Howard D. Thames, Stanley R. Hamilton

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	3381-3382
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	21
Issue number	18
DOIs	https://doi.org/10.1200/JCO.2003.04.156
State	Published - Sep 15 2003

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2003.04.156

Cite this

@article{db359a379dde4266ab69f411eb9d3d2e,

title = "Will identifying or targeting altered marker expression in response to cytotoxic therapy be of prognostic or therapeutic value?",

author = "Crane, {Christopher H.} and Thames, {Howard D.} and Hamilton, {Stanley R.}",

year = "2003",

month = sep,

day = "15",

doi = "10.1200/JCO.2003.04.156",

language = "English (US)",

volume = "21",

pages = "3381--3382",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",